Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium iodoacetate (MIA)-induced OA rat model

Fig. 6

sCCR2 reduces inflammation in small intestine. A Small intestine tissues were immunohistochemically stained with specific antibodies to IL-17, MCP-1, CCR2. B Numbers of positive cells were counted in high-power fields (magnification: ×400) with the aid of NIH ImageJ software and averaged for three randomly selected fields per tissue section. Bars show the mean ± SEM results in three rats per group. The data show the mean ± SEM of three independent experiments. (*p < 0.05, ** p < 0.01, *** p < 0.001)

Back to article page